According to phase 4 trial results, vedolizumab is safer and more effective as a treatment in early Crohn’s disease, compared to late Crohn’s disease.
This open-label, investigator-initiated, phase 4 cohort study enrolled 260 patients with…
According to phase 4 trial results, vedolizumab is safer and more effective as a treatment in early Crohn’s disease, compared to late Crohn’s disease.
This open-label, investigator-initiated, phase 4 cohort study enrolled 260 patients with…